A comparison of the empirical performance of methods for a risk identification system
- PMID: 24166231
- DOI: 10.1007/s40264-013-0108-9
A comparison of the empirical performance of methods for a risk identification system
Abstract
Background: Observational healthcare data offer the potential to enable identification of risks of medical products, and the medical literature is replete with analyses that aim to accomplish this objective. A number of established analytic methods dominate the literature but their operating characteristics in real-world settings remain unknown.
Objectives: To compare the performance of seven methods (new user cohort, case control, self-controlled case series, self-controlled cohort, disproportionality analysis, temporal pattern discovery, and longitudinal gamma poisson shrinker) as tools for risk identification in observational healthcare data.
Research design: The experiment applied each method to 399 drug-outcome scenarios (165 positive controls and 234 negative controls across 4 health outcomes of interest) in 5 real observational databases (4 administrative claims and 1 electronic health record).
Measures: Method performance was evaluated through Area Under the receiver operator characteristics Curve (AUC), bias, mean square error, and confidence interval coverage probability.
Results: Multiple methods offer strong predictive accuracy, with AUC > 0.70 achievable for all outcomes and databases with more than one analytical approach. Self-controlled methods (self-controlled case series, temporal pattern discovery, self-controlled cohort) had higher predictive accuracy than cohort and case-control methods across all databases and outcomes. Methods differed in the expected value and variance of the error distribution. All methods had lower coverage probability than the expected nominal properties.
Conclusions: Observational healthcare data can inform risk identification of medical product effects on acute liver injury, acute myocardial infarction, acute renal failure and gastrointestinal bleeding. However, effect estimates from all methods require calibration to address inconsistency in method operating characteristics. Further empirical evaluation is required to gauge the generalizability of these findings to other databases and outcomes.
Similar articles
-
Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.Drug Saf. 2013 Oct;36 Suppl 1:S107-21. doi: 10.1007/s40264-013-0095-x. Drug Saf. 2013. PMID: 24166228
-
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.Drug Saf. 2013 Oct;36 Suppl 1:S95-106. doi: 10.1007/s40264-013-0101-3. Drug Saf. 2013. PMID: 24166227
-
Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.Drug Saf. 2013 Oct;36 Suppl 1:S159-69. doi: 10.1007/s40264-013-0109-8. Drug Saf. 2013. PMID: 24166232
-
Desideratum for evidence based epidemiology.Drug Saf. 2013 Oct;36 Suppl 1:S5-14. doi: 10.1007/s40264-013-0102-2. Drug Saf. 2013. PMID: 24166219 Review.
-
Trigger Tool-Based Automated Adverse Event Detection in Electronic Health Records: Systematic Review.J Med Internet Res. 2018 May 30;20(5):e198. doi: 10.2196/jmir.9901. J Med Internet Res. 2018. PMID: 29848467 Free PMC article.
Cited by
-
Electronic Health Data for Postmarket Surveillance: A Vision Not Realized.Drug Saf. 2015 Jul;38(7):601-10. doi: 10.1007/s40264-015-0305-9. Drug Saf. 2015. PMID: 26025018 Review.
-
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.Drug Saf. 2014 Aug;37(8):557-67. doi: 10.1007/s40264-014-0189-0. Drug Saf. 2014. PMID: 24985530 Free PMC article.
-
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.Drug Saf. 2018 Apr;41(4):377-387. doi: 10.1007/s40264-017-0618-y. Drug Saf. 2018. PMID: 29185236
-
Transforming Anesthesia Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study.J Med Internet Res. 2021 Oct 29;23(10):e29259. doi: 10.2196/29259. J Med Internet Res. 2021. PMID: 34714250 Free PMC article.
-
Foundational model aided automatic high-throughput drug screening using self-controlled cohort study.medRxiv [Preprint]. 2024 Sep 16:2024.08.04.24311480. doi: 10.1101/2024.08.04.24311480. medRxiv. 2024. PMID: 39148849 Free PMC article. Preprint.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical